Core Insights - Clover Health Investments, Corp. (NASDAQ: CLOV) reported significant growth in Q2, with an increase in members and revenues, but the stock price fell by up to 30% due to rising medical costs across the industry [1] Company Summary - Clover Health's Q2 earnings demonstrated exponential growth in both membership and revenue [1] - Despite the positive earnings report, the company's stock experienced a substantial decline, attributed to industry-wide increases in medical costs following new implementations [1] Industry Summary - The healthcare industry is facing heightened medical costs, which have negatively impacted stock performance for companies like Clover Health [1]